Iontophoresis for ocular drug delivery;Iontoforese no transporte ocular de drogas

Arquivos Brasileiros de Oftalmologia

Volumn 67, Issue 5, 2004, Pages 839-845

  Fialho, Sílvia Ligório ^a   Da Silva Cunha Jr , Armando ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Drug delivery systems; Eye diseases therapy; Eye metabolism; Iontophoresis methods; Technology, pharmaceutical

Indexed keywords

EID: 33748466610     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/S0004-27492004000500028     Document Type: Article

References (38)

1. Sarraf D, Lee DA. The role of iontophoresis in ocular drug delivery. J Ocul Pharmacol. 1994;10(1):69-81.
2. Kalia YN, Naik A, Garrison J, Guy RH. Iontophoretic drug delivery. Adv Drug Deliv Rev. 2004;56(5):619-658
3. Gangarosa LP Sr, Hill JM. Modern iontophoresis for local drug delivery. Int J Pharm. 1995;123(2):159-171
4. Lai PM, Roberts MS. Iontophoresis. In: Roberts MS, Walters KA, editors. Dermal absorption and toxicity assessment. New York: Marcel Dekker; 1998. p.371-414.
5. Leduc S. Introduction des substances medicamenteuses dans la profondeur des tissues par le courant electrique. Ann Electrobiol. 1900;3:545-560
6. Harris R. Iontophoresis. In: Licht S, editor. Therapeutic electricity and ultraviolet radiation. Baltimore: Waverly Press; 1967. p.156-178
7. Gibson LE, Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics. 1959; 23(3):545-549
8. Murray W, Lavine LS, Seifter E. The iontophoresis of C21 esterified glucocorticoids: preliminary report. J Am Phys Ther Assoc. 1963;43(4):579-581
9. Comeau M, Brummett R, Vernon J. Local anesthesia of the ear by iontophoresis. Arch Otolaryngol. 1973;98(2):114-120
10. Gangarosa LP. Iontophoresis for surface local anesthesia. J Am Dent Assoc. 1974;88(1):125-128
11. Gangarosa LP, Park NH. Practical considerations in iontophoresis of fluoride for desensitizing dentin. J Prosthet Dent. 1978;19(2):173-178
12. Gangarosa LP, Hill JM, Thompson BL, Leggett C, Rissing JP. Iontophoresis of vidarabine monophosphate for herpes orolabialis. J Infect Dis. 1986;154 (6):930-934
13. Rigano W, Yanik M, Barone FA, Baibak G, Cislo C. Antibiotic iontophoresis in the management of burned ears. J Burn Care Rehabil. 1992;13(4):407-409
14. Jones RF, Maurice DM. New methods of measuring the rate of aqueous flow in man with fluorescein. Exp Eye Res. 1966;5(3):208-210
15. Hughes L, Maurice D. A fresh look at iontophoresis. Arch Ophthalmol. 1984; 102(12):1825-1829
16. Behar-Cohen F, Parel JM, Pouliquen Y, Thillaye-Goldenberg B, Goureau O, Heydolph S, et al. Iontophoresis of dexamethasone in the treatment of endotoxin-induced-uveitis in rats. Exp Eye Res. 1997;65(4):533-545
17. Behar-Cohen F, Savoldelli M, Parel JM, Goureau O, Thillaye-Goldenberg B, Courtois Y, et al. Reduction of corneal edema in endotoxin-induced-uveitis after application of L-NAME as nitric oxide synthase inhibitor in rats by iontophoresis. Invest Ophthalmol Vis Sci. 1998;39(6):897-904.
18. Behar-Cohen F, El Aouni A, Le Rouic JF, Parel JM, Renard G, Chauvaud D. Iontophoresis: past and future. J Fr Ophtalmol. 2001;24(3):319-327
19. Behar-Cohen F. Drug delivery systems to target the anterior segment of the eye: fundamental bases and clinical applications. J Fr Ophtalmol. 2002;25(5): 537-544
20. Monti D, Saccomani L, Chetoni P, Burgalassi S, Saettone MF. Effect of iontophoresis on transcorneal permeation 'in vitro' of two b-blocking agents, and on corneal hydration. Int J Pharm. 2003;250(2):423-429
21. Frucht-Pery J, Mechoulam H, Siganos CS, Ever-Hadani P, Shapiro M, Domb A. Iontophoresis - gentamicin delivery into the rabbit cornea, using a hydrogel delivery probe. Exp Eye Res. 2004;78(3):745-749
22. Optis Ocular Drug Delivery [text on the Internet]. [cited 2004 Aug 24]. Available from: http://www.optisgroup.com/Technology-Applications.htm
23. Callegan MC, Hobden JA, O'Callaghan RJ, Hill JM. Ocular drug delivery: a comparison of transcorneal iontophoresis to corneal collagen shields. Int J Pharm. 1995;123(2):173-179
24. Sanderson JE, De Riel S, Dixon R. Iontophoretic delivery of non-peptide drugs: formulation optimisation for maximum skin permeability. J Pharm Sci. 1989;78(5):361-364
25. Barza M, Peckamn C, Baum J. Transscleral iontophoresis of gentamicin in monkeys. Invest Ophthalmol Vis Sci. 1987;28(6):1033-1036
26. Asahara T, Shinomiya K, Naito T, Shiota H. Induction of gene into the rabbit eye by iontophoresis: preliminary report. Jpn J Ophthalmol. 2001;45(1):31-39
27. Behar-Cohen FF, El Aouni A, Gautier S, David G, Davis J, Chapon P. Transscleral Coulomb-controlled iontophoresis of methyl-prednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration in ocular tissues and fluids levels. Exp Eye Res. 2002;74(1):51-59
28. Voigt M, De Kozak Y, Halhal M, Courtois Y, Behar-Cohen F. Down-regulation of NOSII gene expression by iontophoresis of anti-sense oligonucleotide in endotoxin-induced uveitis. Biochem Biophys Res Commun. 2002;295(2):336-341
29. Vollmer DL, Szlek MA, Kolb K, Lloyd LB, Parkinson TM. In vivo transscleral iontophoresis of amikacin to rabbit eyes. J Ocul Pharmacol Ther. 2002; 18(6):549-558
30. Berdugo M, Valamanesh F, Andrieu C, Klein C, Benezra D, Courtois Y, et al. Delivery of antisense oligonucleotide to the cornea by iontophoresis. Antisense Nucleic Acid Drug Dev. 2003;13(2):107-114
31. Parkinson TM, Ferguson E, Febbraro S, Bakhtyari A, King M, Mundasad M. Tolerance of ocular iontophoresis in healthy volunteers. J Ocul Pharmacol Ther. 2003;19(2):145-151
32. Brasil. Ministério do Desenvolvimento, Indústria e Comércio Exterior. Instituto Nacional da Propriedade Industrial [texto na Internet]. [citado 2004 Ago 24]. Disponível em: http://www.inpi.gov.br
33. United States. United States Patent and Trademark Office [text on the Internet]. [cited 2004 Aug 24]. Available from:http://www.uspto.gov/patft/index. html
34. United States. Delphion Research Intellectual Property Network [text on the Internet]. [cited 2004 Aug 24]. Available from: www.delphion.com
35. European Patent Office [text on the Internet].[cited 2004 Aug 24]. Available from: http://ep.espacenet.com
36. The Intellectual Property Digital Library Web[text on the Internet]. [cited 2004 Aug 24]. Available from: http://www.wipo.int/ipdl/en/index.jsp
37. Parel J, Behar-Cohen F, inventors. Device for the intraocular transfer of active products by iontophoresis. United States patent US 6, 154, 671;2000.
38. Parkinson TM, Szlek M, Lloyd LB, inventors. Ocular iontophoretic device and method for using the same. United States patent US 6, 697, 668;2004.